can you switch from retatrutide to tirzepatide vs (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide vs Tirzepatide: a Quick

Retatrutide is a weight loss drug that has not yet received approval from the U.S

Although these drugs have been used to treat type 2 diabetes for nearly two decades, it was not until 2021 that the US FDA approved them for treating obesity

Glucagon receptor agonism: Glucagon is a novel element of the therapy that typically raises blood sugar levels in your body, but its agonism promotes increased energy expenditure and fat burning

It is not FDA-approved for any use, it has never been FDA-approved, and PlexusDx does not sell, distribute, or prescribe retatrutide or any other investigational peptide in this category

The study included 3,746,672 people with type 2 diabetes, of whom 4,466 developed thyroid cancer